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 Supplementary Figure 1 
AAV-PHP.eB transduces several brain regions more efficiently than AAV-PHP.B. 
(a-c) The cumulative distribution plots show native GFP fluorescence, measured by the median NLS-GFP intensity within individual 
nuclei in the cortex (a), striatum (b) and within calbindin
+
 Purkinje cell bodies (c). In (a and b), ROIs were drawn manually around each 
DAPI
+
 nuclei. In (c), the ROI detection was automated (see Online Methods and Supplementary Fig. 2). (a-c) The dotted lines 
represent the 50% intersect, where 50% of the cells have the corresponding median intensity or lower. (c) The solid black vertical line 
displays the cutoff point used during the automated detection to classify whether a cell had been transduced with ssAAV-CAG-NLS-
GFP. Cells with a median intensity below or equal to 0.1 were classified as non-transduced while those above 0.1 were classified as 
transduced. (a-c) n = 4 individual animals per group. P ≤ 0.0001 for each region, Kolmogorov-Smirnov test. 
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 Supplementary Figure 2 
An automated cell detection pipeline used for counting Purkinje cells in the cerebellum. 
The pipeline used for automated cell body and nucleus detection. (a) To detect cell bodies from the original image, a morphological 
filter with a disk-shaped structural element is first used to blur thin fibrous processes (morphological filtering). A circular Hough 
transform was subsequently applied to the filtered image (circular object detection). Red circles indicate the objects detected, each of 
which corresponds to a single cell body. (b) In Fig. 2c, we further analyzed the GFP channel to detect the nucleus of each cell. First, 
the same area at each cell body region was cropped from the GFP image (cropped image of each cell body). The background of each 
cropped image, estimated by 2D Gaussian smoothing with a standard deviation of 5-fold the cell body size, was subtracted 
(background subtraction). After thresholding the image to make it binary (binarization), the 2-D convex hull of the object (convex hull) 
was obtained as the final nuclear region (NLS). 
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 Supplementary Figure 3 
Representative immunohistochemistry in the cortex and striatum after transduction with AAV-PHP.B or AAV-PHP.eB. 
Single-plane confocal images of native GFP fluorescence (green) after immunohistochemistry (IHC) with DAPI (DNA labeling, blue), 
NeuN (neuronal marker, magenta) and S100 (glial marker, red) in (a) cortex or (b) striatum. These data are presented in support of 
Fig. 2. All scale bars are 50 µm. All imaging and display conditions for the GFP channel are matched across panel pairs to allow for 
comparisons. All images are from tissue extracted at three weeks post intravenous administration of ssAAV-CAG-NLS-GFP at 1 x 10
11
 
vg to adult mice. 
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 Supplementary Figure 4 
AAV-PHP.S transduces peripheral organs through intravenous delivery in adult mice.  
(a) Representative images of the liver, lungs and cardiac muscle transduced by AAV9 (top) or AAV-PHP.S (bottom). (b) 
Representative images of several layers of the stomach (longitudinal muscle, myenteric plexus, and circular muscle) transduced by 
AAV9 (top) or AAV-PHP.S (bottom). The myenteric plexus also contains muscle cells due to the uneven topography of the stomach. 
(c) Representative images of the submusocal plexus stained with neuronal marker PGP9.5 (red) and astrocyte marker S100b (blue) in 
the duodenum, jejunum, ileum, and proximal colon. (a-c) All images show native GFP fluorescence taken with confocal microscopy. 
Images in (a) are 20 µm maximum intensity projections (MIPs) and images in (b and c) are single-plane images. All imaging and 
display conditions for the GFP channel are matched across panel pairs to allow for comparisons. All scale bars are 50 µm. All images 
are from tissue extracted three weeks post intravenous administration of ssAAV-CAG-NLS-GFP at 1 x 10
12
 vg to adult mice. All 
experiments and imaging for direct comparisons were performed in parallel.  
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 Supplementary Figure 5 
The FLPo-FRT two-component system allows sparse gene expression. 
(a) Schematic of the two viral vectors used for sparse gene expression with FlpO recombinase encoded in one viral vector and a 
transgene flanked by FRT sites on a second viral vector. In the basal state, the XFP is expressed in a double inverted orientation 
(fDIO) and upon the presence of FLPo is inverted into the orientation in line with the CAG promoter for expression. (b) Representative 
images of native mNeonGreen fluorescence two weeks after intravenous administration of ssAAV-PHP.B:CAG-fDIO-mNeonGreen at 
1 x 10
12
 vg/mouse together with the indicated dose of ssAAV-PHP.B:EF1α-FLPo. (c) Magnified images of the cortex, striatum, and 
cerebellum. Scale bars are 1 mm (b) and 50 µm (c). 
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 Supplementary Figure 6 
The use of the tetracycline-inducible system with viral vectors provides tunable dense to sparse gene expression. 
(a) A two-component vector system consisting of one virus, ssAAV-PHP.B:TRE-mNeonGreen, delivered at 1 x 10
12
 vg into adult mice, 
and a second virus, ssAAV-PHP.B:CAG-tTA, the dose of which was varied across mice. As a control, ssAAV-PHP.B:TRE-
mNeonGreen was delivered alone to observe any basal expression from the ssAAV-PHP.B:TRE-mNeonGreen. All experimental, 
imaging and display conditions are matched across images. (b) Representative 20 µm MIPs of native mNeonGreen fluorescence from 
the cortex, striatum, and cerebellum at high and low activation doses. (c and d) Measurements of the shortest cell-to-cell distance (c) 
and cell density (d) in the cortex, striatum and cerebellum. n = 3 sections per group, mean ± SEM,unpaired t-test (***p ≤ 0.001; **p ≤ 
0.01; *p ≤ 0.05; n.s., p ≥ 0.05). (e) A MIP image of a coronal section taken from the olfactory bulb of a Tbx21-Cre mouse transduced 
with vector-assisted spectral tracing (VAST) transgenes. The VAST cocktail consist of ssAAV-PHP.eB:TRE-DIO-3XFP (1 x 10
12
 vg 
total dose) and sAAV-PHP.eB:ihSyn1-tTA (1 x 10
10
 vg – high dose) or (1 x 10
8
 vg – low dose). In (e, right) the inset box in gray 
represents a high magnification of the region of interest outlined. Scale bars are 1 mm (a) and 50 µm (b and e). All images are native 
GFP fluorescence taken with confocal microscopy.  
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 Supplementary Figure 7 
A positive feedback loop within the tTA inducer vector enhances gene expression.  
Schematic of the two-component viral vector system without (a) and with (b) an inducible positive feedback loop with the viral vector 
containing the tTA. The schematic shows tTA protein (magenta hexagons) binding onto TRE elements (blue lines) to activate 
expression of (a) mNeonGreen or (b) mNeonGreen and the tTA containing vector. (c) Representative confocal images of sagittal brain 
sections transduced by the no-feedback vector and (d) positive-feedback tTA vector at 1 x 10
9
 vg. Both tTA inducers were co-
administered with 1 x 10
12
 vg of the mNeonGreen viral vector. Scale bar in (c) is 1 mm.  
Nature Neuroscience: doi:10.1038/nn.4593
 Supplementary Figure 8 
Cell-type-restricted expression and sparse labeling in the enteric nervous system using AAV-PHP.S together with neuron-
specific gene regulatory elements or Cre transgenic mice.  
Images show XFP expression within the myenteric plexus. (a) ssAAV-PHP.S:hSyn1-3XFP was administered intravenously at a total 
dose of 1 x 10
12
 vg. (b) ssAAV-PHP.S:CAG-DIO-3XFP was administered intravenously at a total dose of 1 x 10
12
 vg to ChAT-IRES-
Cre transgenic mice to achieve cell type-specific expression in cholinergic neurons. (c) Sparse labeling with the VAST system in the 
proximal colon of a ChAT-IRE-Cre transgenic using ssAAV-PHP.S-TET-DIO-3XFP at 1 x 10
12
 vg and ssAAV-PHP.S-ihSyn-DIO-tTA at 
1 x 10
10
 vg. Color-coded square boxes display neurons traced manually in Imaris v8.3. (d) Rectangular boxes show higher 
magnification views highlighting how sparse multicolor labeling facilitates tracing of closely aligned processes. Double arrows mark 
traced processes. Scale bars in (a and d) are set to 50 µm and in (c) to 200 µm. 
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SUPPLEMENTARY TABLE 1
Capsid sequences, viral production efficiency, and Cre-selection lines
Chan et al., 2017
Cre selection line(s) Amino acids*  Nucleotide sequence* % of total recovered sequences
Average post purification yield 
per 150mm dish (vg)
AAV9 Parent SAQ[7-mer]A AGTGCCCAA__(7-mer insertion)__GCA 1.28 x 1012 ± 5.97 x 1011
AAV-PHP.S GFAP-Cre SAQQAVRTSLA AGTGCCCAACAGGCGGTTAGGACGTCTTTGGCA 33% 4.11 x 1012 ± 1.31 x 1012
AAV-PHP.B GFAP-Cre SAQTLAVPFKA AGTGCCCAAACTTTGGCGGTGCCTTTTAAGGCA 2.45 x 1012 ± 1.02 x 1012
AAV-PHP.eB GFAP-,Vgat- and
Vglut2-Cre
SDGTLAVPFKA AGTGATGGGACTTTGGCGGTGCCTTTTAAGGCA
15.7%, 12.1%, and 
11.1%, respectively 3.06 x 10
12 ± 1.18 x 1012
*Starting amino acid or codon for AAV9 = 586
Supplementary Table 1 – Cre-selection lines, capsid sequences, and viral production efficiency
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Promoter Efficiency (%) Dosage (vg)
FEV/Ple67
Mouse tyrosine hydroxylase
Length (bp)
2202
2571
DRN: 67
DRN: 57 VTA: 86
MRN: 48
SNc: 99
Specificity (%)
DRN: 89
DRN: 22 VTA: 81
MRN: 55
SNc: 81
1 x 1012
1 x 1012
3 x 1011mDlx w/ chimeric intron CTX: 81 HPC: 90 HPC: 82CTX: 87 530
a
SUPPLEMENTARY TABLE 2
Dosage, promoter length, transduction efficiency, and specificity of the gene regulatory elements tested
Chan et al., 2017Nature Neuroscience: doi:10.1038/nn.4593
Chan et al., 2017
SUPPLEMENTARY TABLE 3
Summary of AAV resources
Applications within paper Vector name pAAV- Expression class
TREa-mTurq2
TRE-mNeonG
TRE-mRuby2
TRE-DIO-mTurq2
TRE-DIO-mNeonG
TRE-DIO-tdTomato
TRE-DIO-mRuby2
CAG-fDIO-mNeonG Flp dependent
CAGb-tTA
hSyn1c-tTA
ihSyn1d-tTA
ihSyn1-DIO-tTA
CAG-mTurq2
CAG-mNeonG
CAG-mRuby2
CAG-NLS-GFP-NLS
CAG-DIO-mTurq2
CAG-DIO-mNeonG
CAG-DIO-mRuby2
hSyn1-mTurq2
hSyn1-mNeonG
hSyn1-mRuby2
MBPe-eYFPf
MsTHf-GFP
GFAPg-mKate2.5f
mDlxh-NLS-mRuby2
aTREpi = second generation tetracycline-regulated promoter 
bCAG = synthetic promoter containing the cytomegalovirus early enhancer element, the promoter, f irst exon and f irst intron of chicken beta-actin 
gene, and the splice acceptor from the rabbit beta-globin gene 
chSyn1 = human Synapsin I promoter
dihSyn1 = inducible intron human Synapsin I promoter
eMBP = myelin basic protein promoter
f MsTH = mouse tyrosine hydroxylase promoter
gGFAP = glial f ibrillary acidic protein promoter
hmDlx = mouse distal-less homeobox promoter
• Expression of XFPs  that are constitutive or 
Cre-dependent  (Fig. 1c-g), (Fig. 2a-c), (Fig. 
3a,c), (Fig. 4d), and (Supplementary Fig. 4a-
c).
• Expression of XFPs under the control of cell 
type-specific gene regulatory elements (Fig. 
4a) and (Fig. 5a-e).
• Vector-assisted spectral tracing (VAST) 
expression vectors of XFPs that are tunable 
in the density of expression in a constitutive, 
cell type-specific, or recombinase dependent 
manner (Fig. 4e,g), (Supplementary Fig. 5a-
c), (Supplementary Fig. 6a,b,e),  
(Supplementary Fig. 7a-d), (Supplementary 
Fig. 8a-d). 
Tu
na
bl
e 
ex
pr
es
si
on
Ti
ss
ue
 w
id
e
 e
xp
re
ss
io
n
C
el
l t
yp
e-
sp
ec
ifi
c 
ex
pr
es
si
on
tTA-dependent
Cre-dependent
Cell type-specific
Cre- and
 tTA-dependent
Inducer
Constitutive
Nature Neuroscience: doi:10.1038/nn.4593
